All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

NAD+ Dosage Guide: Complete Guide

Learn about NAD+ dosing for IV infusion, subcutaneous injection, and oral precursors. Evidence-based dosage guidance with physician oversight from Form...

By Dr. Sarah Chen, PharmD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Sarah Chen, PharmD · Reviewed by Dr. David Kim, MD, FACE

NAD+ Dosage Guide: Complete Guide custom 2026 header image for Peptide Therapy
Custom header image for NAD+ Dosage Guide: Complete Guide, Peptide Therapy, and better treatment decision-making.
In This Article

This article is part of our Peptide Therapy collection. See also: GLP-1 Guides | Provider Comparisons

Search and AI answer brief

Practical answer: NAD+ Dosage Guide: Complete Guide

Learn about NAD+ dosing for IV infusion, subcutaneous injection, and oral precursors. Evidence-based dosage guidance with physician oversight from Form...

Short answer

Learn about NAD+ dosing for IV infusion, subcutaneous injection, and oral precursors. Evidence-based dosage guidance with physician oversight from Form...

Search intent

This page answers a specific Peptide Therapy question rather than a generic overview.

What to verify

peptide evidence quality, safety and contraindications

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Learn about NAD+ dosing for IV infusion, subcutaneous injection, and oral precursors. Evidence-based dosage guidance with physician oversight from FormBlends.

Quick Answer: NAD+ dosing varies by delivery method. IV infusions typically range from 250 mg to 750 mg per session. Subcutaneous injections commonly use 50 mg to 200 mg per dose. Oral precursors (NMN, NR) are studied at 250 mg to 1,200 mg daily. Your physician should determine the right dose for your goals and health profile. NAD+ therapy isn't FDA-approved for any medical condition.

What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of metabolic reactions in every cell of your body. It supports mitochondrial energy production, DNA repair, and the activity of sirtuins and other regulatory enzymes.

NAD+ levels decline with age, and restoring them through supplementation has become a central focus of longevity and metabolic health research . Because NAD+ can be delivered through several routes, each with different bioavailability and dosing ranges, understanding the options is important for getting the most out of therapy.

This guide covers the dosing protocols most commonly used in clinical practice and research. But the right dose for you depends on your individual health profile, goals, and physician's assessment.

NAD+ Dosing by Delivery Method

IV NAD+ Infusion Dosing

Intravenous infusion delivers NAD+ directly into the bloodstream, bypassing the digestive system entirely. This provides near-100% bioavailability and is considered the most direct method of raising systemic NAD+ levels.

Popular Therapeutic Peptides by Use Case Clinical Interest Score 0 22 44 66 88 88 82 78 75 70 BPC-157 TB-500 Sermorelin Ipamorelin GHK-Cu Based on published peptide research literature
Popular Therapeutic Peptides by Use Case. Based on published peptide research literature.
View data table
Bar chart showing popular therapeutic peptides by use case: BPC-157 (88), TB-500 (82), Sermorelin (78), Ipamorelin (75), GHK-Cu (70)
CategoryClinical Interest ScoreDetail
BPC-15788Tissue repair and gut healing
TB-50082Injury recovery
Sermorelin78Growth hormone support
Ipamorelin75Anti-aging and recovery
GHK-Cu70Skin and tissue repair
Illustration for NAD+ Dosage Guide: Complete Guide

Typical dosing ranges:

  • Low dose (introductory): 250 mg per session. This is often used for first-time patients to assess tolerance.
  • Standard dose: 500 mg per session. This is the most commonly used dose in clinical settings for general wellness and energy support.
  • High dose: 750 mg to 1,000 mg per session. Sometimes used for intensive protocols or specific therapeutic goals under close physician supervision.

Infusion rate: The infusion is typically administered over 2 to 4 hours. Faster rates increase the likelihood of side effects such as chest tightness and nausea. Your clinician will adjust the drip rate based on your comfort.

Frequency: Initial protocols often involve a loading phase of 2 to 4 sessions over 1 to 2 weeks, followed by maintenance sessions every 2 to 4 weeks. Your physician will tailor the frequency to your needs.

Subcutaneous NAD+ Injection Dosing

Subcutaneous injection offers a practical at-home alternative to IV infusion. The NAD+ is absorbed gradually from the injection site into the bloodstream. Bioavailability is lower than IV but significantly higher than oral administration.

Typical dosing ranges:

  • Starting dose: 50 mg to 100 mg per injection. This allows assessment of tolerance and response.
  • Maintenance dose: 100 mg to 200 mg per injection, administered 2 to 5 times per week depending on the protocol.

Injection volume: Concentration of compounded NAD+ solutions varies, but injections are typically 0.5 mL to 1 mL per dose. Smaller volumes are generally more comfortable.

For step-by-step injection guidance, see our NAD+ how to inject guide.

Oral NAD+ Precursor Dosing (NMN and NR)

Oral precursors are converted to NAD+ through metabolic pathways after absorption. They offer the greatest convenience but have lower bioavailability compared to injectable routes.

NMN (Nicotinamide Mononucleotide):

  • Clinical trials have studied doses ranging from 250 mg to 1,200 mg per day.
  • A common protocol is 250 mg to 500 mg taken once daily in the morning.
  • Higher doses (up to 1,200 mg) have been used in research settings and shown to be well tolerated.

NR (Nicotinamide Riboside):

  • Clinical trials have typically used doses of 250 mg to 1,000 mg per day.
  • A common starting dose is 300 mg per day, sometimes divided into two doses.

Both NMN and NR have demonstrated the ability to raise blood NAD+ levels in humans in clinical trials.

Factors That Influence Your Ideal Dose

NAD+ dosing isn't one-size-fits-all. Several factors will influence what your physician recommends:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Age

NAD+ levels decline with age, so older individuals may benefit from higher or more frequent dosing to achieve meaningful restoration. A 60-year-old starting NAD+ therapy may need a different protocol than a 35-year-old.

Health Goals

The reason you're pursuing NAD+ therapy matters. General wellness and energy support may require different dosing than protocols aimed at specific health concerns. Your physician will align the dose with your objectives.

Body Weight

Larger individuals may require higher doses to achieve comparable tissue NAD+ levels. Some clinicians adjust IV dosing based on body weight, though standardized weight-based protocols haven't been established in clinical trials.

Tolerance and Response

Some people are more sensitive to NAD+ therapy than others. Starting with a lower dose and adjusting based on your response and any side effects is a sound approach. See our NAD+ side effects guide for information on managing tolerability.

Combination Therapy

If you're using NAD+ alongside other peptide therapies or supplements, your physician may adjust the dose to account for potential combined effects or interactions.

Sample Dosing Protocols

The following are examples of dosing protocols commonly used in clinical practice. These are general frameworks, not prescriptions. Your physician will create a personalized protocol.

General Wellness Protocol

  • Subcutaneous NAD+ 100 mg, 3 times per week
  • Or oral NMN 500 mg daily
  • Duration: ongoing, with periodic physician review

Intensive Loading Protocol

  • IV NAD+ 500 mg, 3 to 4 sessions over 10 to 14 days
  • Transition to subcutaneous NAD+ 100 to 200 mg, 2 to 3 times per week for maintenance

Anti-Aging and Longevity Protocol

  • Subcutaneous NAD+ 150 mg, 3 to 5 times per week
  • Monthly IV NAD+ 500 mg booster session (optional)
  • Duration: ongoing, with periodic lab work and physician review

Timing and Administration Tips

  • Morning dosing: Many clinicians recommend taking NAD+ or its precursors in the morning, as it supports cellular energy production and may interfere with sleep if taken late in the day.
  • With or without food: IV and subcutaneous routes are unaffected by food intake. Oral precursors may be taken with or without food, though taking them with a light meal may reduce mild GI symptoms.
  • Consistency matters: For subcutaneous and oral protocols, maintaining a consistent schedule helps sustain improved NAD+ levels over time.
  • Hydration: Staying well hydrated before and after any NAD+ administration can reduce side effects such as nausea and lightheadedness.

Safety Considerations

NAD+ has demonstrated a favorable safety profile across clinical studies. Trials of oral NMN at doses up to 1,200 mg daily reported no serious adverse events . IV and subcutaneous administration carry slightly higher side effect rates, but effects are generally mild and manageable.

The most important safety practice is working with a qualified physician who can monitor your response and adjust your protocol. Self-dosing without medical guidance isn't recommended.

For a full overview of side effects, read our NAD+ side effects guide.

How FormBlends Can Help

Determining the right NAD+ dose requires medical expertise. At FormBlends, our licensed physicians evaluate your health history, goals, and tolerance to create a personalized dosing protocol.

When you work with us, you receive:

  • A thorough medical evaluation before therapy begins
  • A customized dosing protocol tailored to your needs
  • Pharmaceutical-grade NAD+ from licensed compounding pharmacies
  • Ongoing physician oversight with dose adjustments as needed

We believe that proper dosing, guided by a physician, is important for getting the best results from NAD+ therapy while minimizing side effects.

Frequently Asked Questions

What is the best dose of NAD+ for beginners?

For IV infusions, 250 mg is a common starting dose. For subcutaneous injections, 50 to 100 mg is typical. For oral NMN, 250 to 500 mg daily is a reasonable starting point. Your physician will adjust based on your response.

How often should I take NAD+?

Frequency depends on the delivery method and your goals. IV infusions are typically done weekly to monthly. Subcutaneous injections are commonly administered 2 to 5 times per week. Oral precursors are usually taken daily.

Can I take too much NAD+?

Clinical trials have tested NAD+ precursors at doses up to 1,200 mg daily without serious adverse effects. But taking more than your physician recommends isn't advisable. Higher IV doses or faster infusion rates increase the likelihood of side effects like chest tightness and nausea.

Should I take NAD+ in the morning or at night?

Morning administration is generally preferred because NAD+ supports energy production and circadian rhythm regulation. Taking it late in the day may cause difficulty sleeping in some individuals.

How long should I stay on NAD+ therapy?

There's no established maximum duration. Many physicians recommend ongoing therapy with periodic check-ins and lab work to assess response. Your physician will help you determine the appropriate duration based on your goals and health status.

Ready to Learn More?

If you want personalized guidance on NAD+ dosing, FormBlends can connect you with a licensed physician who will create a protocol tailored to your needs. Our team is here to help you get the most out of NAD+ therapy safely and effectively.

Schedule Your Free Consultation

Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. NAD+ therapy isn't FDA-approved for any medical condition. The dosing information presented here is based on clinical research and common clinical practice and shouldn't be used as a substitute for professional medical guidance. Always consult with a licensed healthcare provider before beginning any therapy. Individual results may vary. FormBlends doesn't claim that NAD+ cures, treats, or prevents any disease.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For NAD+ Dosage Guide: Complete Guide, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Peptide decision path

Move from research interest to supervised review

Direct answer

NAD+ Dosage Guide: Complete Guide should be evaluated through research status, legal access, source quality, safety context, and clinician oversight rather than a shortcut purchase decision.

Evidence check

Useful peptide pages should separate human data, animal research, mechanistic evidence, and marketing claims.

Safety check

Peptides can vary by legal status, compounding pathway, purity testing, patient history, and interaction risk.

Next step

If the topic still fits your goal after reading, the get-started flow should collect the clinical context needed for provider review.

FormBlends Editorial Context

Reviewed May 14, 2026

Learn about NAD+ dosing for IV infusion, subcutaneous injection, and oral precursors. Evidence-based dosage guidance with physician oversight from Form Blends. "NAD+ Dosage Guide: Complete Guide" is most useful when you treat it as decision prep, not a shortcut. The page is built around dosing literacy and clinician follow-up, with the highest-value checks sitting around dosing. Because this article has 9 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for NAD+ Dosage Guide

This update makes NAD+ Dosage Guide more specific by tying BPC-157, safety signals, nad, dosage, complete to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable peptide therapy summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

NAD+ Dosage Guide custom 2026 image for peptide therapy on FormBlends

Custom 2026 image for NAD+ Dosage Guide, peptide therapy, and better treatment decision-making.

Image description: Unique image for this page covering NAD+ Dosage Guide, peptide therapy, safety, cost, provider selection, and patient decision-making.

Download the Peptide Quick Reference Card

A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Sarah Chen, PharmD

Clinical Pharmacist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.